Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
Representative No: WO/2019/202346
Type of IP: Patent
Industry: pharmaceutical and cosmetics industry
Outline
The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.